Off-Label Pharmacovigilance

被引:0
作者
I. Ralph Edwards
机构
[1] Uppsala Monitoring Centre,
来源
Drug Safety | 2011年 / 34卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:795 / 797
页数:2
相关论文
共 14 条
[1]  
Levi M(2010)Safety of recombinant activated factor VII in randomized clinical trials N Engl J Med 363 1791-800
[2]  
Levy JH(2008)An evaluation of eptacog alfa in nonhaemophiliac conditions Drugs 68 1665-89
[3]  
Andersen HF(2002)Labelling and ‘Dear Doctor’ letters: are they noncommittal? Drug Saf 25 1051-5
[4]  
Mallarkey G(1973)Postpartum purpura fulminans: successful management with streptokinase BMJ 3 329-30
[5]  
Brighton T(1980)Malaria with disseminated intravascular coagulation and peripheral tissue necrosis successfully treated with streptokinase BMJ 280 1252-3
[6]  
Thomson A(2004)Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study Crit Care Med 32 1777-80
[7]  
van Grootheest AC(undefined)undefined undefined undefined undefined-undefined
[8]  
Edwards IR(undefined)undefined undefined undefined undefined-undefined
[9]  
Preston FE(undefined)undefined undefined undefined undefined-undefined
[10]  
Edwards IR(undefined)undefined undefined undefined undefined-undefined